| Literature DB >> 35789736 |
Farzin Halabchi1, Maryam Selk-Ghaffari2, Behnaz Tazesh2, Behnaz Mahdaviani2.
Abstract
Purpose: Disturbance to physical and psychological characteristics among COVID-19 survivors are not uncommon complications. In the current systematic review, we aimed to investigate the role of exercise rehabilitation programs, either in acute or post-acute phase, on COVID-19 patients' outcomes.Entities:
Keywords: COVID-19; Exercise; Rehabilitation; SARS-Cov-2; Systematic review
Year: 2022 PMID: 35789736 PMCID: PMC9244056 DOI: 10.1007/s11332-022-00966-5
Source DB: PubMed Journal: Sport Sci Health ISSN: 1824-7490
Fig. 1PRISMA flowchart of systematic literature search on exercise rehabilitation and COVID-19 outcomes
Results of quality assessment of included observational studies using the Joanna Briggs Institute (JBI) critical appraisal checklist
| Study | Q1 | Q2 | Q3 | Q4 | Q5 | Q6 | Q7 | Q8 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Evaraerts et al. 2021 | No | Yes | Yes | Yes | No | No | Yes | Yes | |||
| Maniscalco et al. 2021 | No | Yes | Yes | Yes | No | No | Yes | Yes | |||
| Olezene et al. 2021 | No | Yes | Yes | Yes | No | No | Yes | Yes | |||
| Rosen et al. 2020 | No | Yes | Yes | Yes | No | No | Yes | Yes | |||
| Zampogna et al. 2021 | Yes | Yes | Yes | Yes | No | No | Yes | Yes | |||
| Zhang et al. 2021 | Yes | Yes | Yes | Yes | No | No | No | Yes | |||
Fig. 2Results of quality assessment of included intervention studies using the Cochrane risk of bias tool. a Traffic light plot and b summary plot
Summary of intervention studies
| Author and year | Design | Sample size (intervention/control ratio) | Age (year); mean (SD) | Participants | Exercise rehabilitation versus comparator | Rehabilitation duration | Onset of rehabilitation | Outcome(s) |
|---|---|---|---|---|---|---|---|---|
| Abodonya et al. 2021 [ | Pilot clinical trial | 42 (ratio: 1:1) | 48.05 (8.85) | ICU admitted patients | IBE + IMT [6 inspiratory cycles, threshold load with 50% of the MIP] vs. IBE | 2 weeks | Post-acute phase | Exercise capacity (walking distance in 6MWT) [ Psychological aspect (Eq-5D-3L score) [ Respiratory function (FEV1%, FVC, DSI) [ All significant in favor of IMT group |
| Andre et al. 2021 [ | Pilot clinical trial | 11 | 86.6 (6.3) | Hospitalized patients | MATCH intervention: unsupervised validated physical activity | Mean: 9.3 days | Acute phase | Exercise capacity (including Sit to stand test, semi-tandem and side by side stand, walking speed) Psychological aspects (including ADL, HAD anxiety/depression) Non-significant |
| Gonzalez-Gerez et al. 2021 [ | Pilot randomized clinical trial | 38 (ratio: 1:1) | Intervention: 40.79 (9.84), Control: 40.32 (12.53) | Mild cases | Home breathing exercise vs. control | 7 days | Acute phase (within the first 40 days), outpatient | Exercise capacity (including 6MWT, 30STST) Respiratory function (including MD12, Borg Scale) All significant in favor of exercise group ( |
| Liu et al. 2020 [ | Randomized clinical trial | 72 (ratio: 1:1) | Intervention: 69.4 (8), Control: 68.9 (7.6) | Hospitalized patients | Respiratory muscle training, cough exercise, diaphragmatic training, stretching, and home exercise, (two sessions/week, once a day for 10 min) vs. no rehabilitation | 6 weeks | Post-acute phase | Exercise capacity (including 6MWT) Psychological aspects (including SF36, SAS) Respiratory function (including FEV1, FVC, FEV/FVC%, TLCO%) All significant in favor of intervention group ( |
| Liu et al. 2021 [ | Randomized clinical trial | 140 (ratio: 1:1) | NA | Hospitalized mild COVID-19 | Group psychological intervention + pulmonary rehabilitation exercise (including five-tone breathing and Baduanjin exercises) vs. conventional nursing methods | 1 month | Acute phase | Psychological aspects (including SAI [ All significant in favor of intervention group |
| Mohamed et al. 2021 [ | Pilot randomized clinical trial | 30 (ratio: 1:1) | Intervention: 44.56 (4.25) Control: 35.25 (3.96) | Mild and moderate cases | Aerobic exercise with moderate intensity (3 sessions per week with duration of 40 min) | 2 weeks | Acute phase | Psychological aspects (WURSS) blood immune biomarkers significant difference (WURSS, leukocyte, lymphocyte, and IgA) and non-significant difference (IL-6, IL-10, TNF-alpha) in favor of intervention group |
| Ozlu et al. 2021 [ | Randomized clinical trial | 67 (ratio: 33: 34) | Intervention: 36.48 (11.63) Control: 33.15 (11.90) | Hospitalized COVID-19 patients | The progressive and supervised muscle relaxation training, (twice a day) vs. routine care | 5 days | Acute phase | Psychological aspects (including SAI, RCSQ) All significant in favor of intervention group ( |
| Rodriguez-Blanco et al. 2021 [ | Pilot randomized clinical trial | 36 (ratio: 1:1) | Intervention: 39.39 (11.74) Control: 41.33 (12.13) | Mild-to-moderate cases | Resistance and strength training vs. control | 1 week | Acute phase (within the first 40 days), outpatient | Exercise capacity (including 6MWT, 30STST) Respiratory function (Borg Scale) All significant in favor of exercise group ( |
| Tang et al. 2021 [ | Clinical trial | 33 | 43.2 (10.4) | 28 mild/ moderate, 5 severe/critical cases | Liuzijue exercise (a type of traditional Chinese mind body exercise including breathing training), once a day, 20 min | 4 weeks | Post-acute phase | Exercise capacity (walking distance in 6MWT [ Psychological aspects (including QOL: SF36-PF [ Respiratory function (including MIP [ All significant in favor of intervention group |
ADL, activities of daily living score; DSI, Dyspnea Severity Index; Eq-5D-3L, EuroQuality-5-dimensions-3-levels; FEV1, forced expiratory volume in one second; FIM, Functional Independence Measure Scale; FVC, forced vital capacity; HAD, Hospitalized Anxiety and Depression Scale; HAMA, Hamilton Anxiety Rating Scale; HAMD, Hamilton Depression Rating Scale; IBE, incentive breathing exercise; IMT, inspiratory muscle training; MD12, multidimensional dyspnoea-12; MIP, maximal inspiratory pressure; mMRC, modified British Medical Research Council; PSQI, Pittsburgh Sleep Quality Index Scale; QOL, quality of life; RCSQ, The Richards–Campbell Sleep Questionnaire; SAI, State Anxiety Inventory; SAS, Self-rating Anxiety Scale; SDS, Self-rating Depression Scale; SF-36, 36-Item Short Form Health Survey; SF36-PF, SF36-Physical Functioning; SF36-RP, SF-36-Role-Physical; SPPB, Short Physical Performances Battery; WURSS, Wisconsin Upper Respiratory Symptom Survey; 6MWT, six-minutes walking test; 30STST, thirty-second sit-to-stand test
Summary of observational studies
| Author and year | Design | Sample size (case/control ratio) | Age (years) [mean (SD)/median (IQR)] | Participants | Exercise rehabilitation vs. comparator (if available) | Rehabilitation duration | Onset of rehabilitation | Outcomes |
|---|---|---|---|---|---|---|---|---|
| Chikhanie et al. (27) 2021 | Cohort | 42 including 21 COVID patients | 70.9 (10.6) | Severe COVID patients with at least one comorbidity including obesity, diabetes, cardiovascular, respiratory as well as cancer | Respiratory exercises, strengthening, and balance training. In some cases, walking, cycling and gymnastics may also be done | Mean: 27.6 (14.2) days | Post-acute phase | Significant ( (FEV1%, FVC%, PImax, PEmax) Non-significant improvement in Psychological aspects (Quality of life, post-traumatic stress), Respiratory function (Percent of patients needed Oxygen therapy, Minimal SpO2 (%), End-of-test dyspnea (Borg)) |
| Daynes et al. 2021 [ | Cohort | 30 | 58 | 26 hospitalized patients (21 patients with mechanical ventilation) | Two sessions weekly, supervised rehabilitation program including aerobic exercise (walking/ treadmill based), strength training of upper and lower limbs and online educational discussions | 6 weeks | Post-acute (mean of 125 days post infection) | Significant improvement in Exercise capacity (Incremental Shuttle Walking Test Psychological aspects (Montreal Cognitive Assessment Non-significant in Hospital Anxiety and Depression Scale Hospital Anxiety and Depression Scale |
| Everaerts et al. 2021 [ | Cross-sectional | 22 | 54.5 (47–61) | Hospitalized patients (15 ICU admitted patients) | Progressive endurance and resistance training including treadmill, cycle/ arm ergometer, stair climbing, step, leg and chest press | 12 weeks | Acute phase | Significant improvement in Exercise capacity (including 6MWD, hand grip force, quadriceps force, work load and peak VO2 via CPET) and Respiratory function (including FEV1, TLC, DLCO, MIP, MEP). Deterioration in Psychological aspects (including HADS anxiety and depression score, MoCA, return to work) |
| Hameed et al. 2021 [ | Cohort | 106 (44: VPT/25: HPT/17:IE/20: no rehabilitation) | VPT: 60 (14), HPT: 57 (14), IE: 59 (20), none: 58 (18) | Persistent COVID-19 patients including mild to critically severe cases | Tele-medicine rehabilitation program including VPT, HPT, IE Vs. no rehabilitation | 2 weeks | Post-acute phase | Data on 53 patients with follow-up visits showed improvement in Exercise capacity (STSS, STS) in VPT, and HPT groups. In addition, STS changes were significant in IE group. Neither STSS changes nor STS changes were significant among patients with no rehabilitation |
| Jiandani et al. 2020 [ | Cohort | 278 | ICU: 54.82 (13.09), SDU: 51.71 (14.57) | COVID-19 patients admitted in ICU and a step-down unit (SDU) of the hospital | Position change, Respiratory physiotherapy consist of deep breathing exercises, paced breathing, active cycle of breathing technique (ACBT), and diaphragmatic breathing | 7 days | Post-acute phase | Significant improvement in ICU mobility score (IMS) among ICU patients ( |
| Li et al. 2021 [ | Cohort | 13 | Age range (50–85) | Severe and critical COVID-19 cases | Respiratory physiotherapy, positioning, mobility and IMT exercises | A rang of 3–21 days, 2 sessions of 30–40 min in a day | Acute phase | Improvement in Respiratory function (P/F ratio, PEFR, MIP, and Borg Dyspnea Scale), and Functional outcomes (Medical Research Council Sum Score, the Physical Function in Intensive Care Test score, De Morton Mobility Index, and Modified BI) |
| Maniscalco et al. 2021 [ | Cross-sectional | 95 (49 without comorbidity, 46 with comorbidity) | Comorbid patients: 65.3 (1.2), non-comorbid patients: 61.5 (1.6) | COVID-19 patients with and without comorbidity | 6 sessions/week: pulmonary rehabilitation program including progressive exercise training (upper and lower extremity strength and flexibility training, treadmill and outdoor walking and stationary cycling at moderate-to-high intensity according to dyspnea and fatigue symptoms), dietary and psychosocial counselling | 5 weeks (30 sessions) | Post-acute phase | Improvement in Exercise capacity (6MWD) and Respiratory function (FEV1, FVC, and DLCO%) in both groups of patients with or without comorbidity |
| Martin et al. 2021 [ | Cohort | 27 (14: 13) | 61.5 (10.5) Case: 60.8 (10.4), control: 61.9 (10.7) | Severe, and critically ill cases | The synchronous telerehabilitation program including endurance exercises, upper and lower body strength training. Encouragement to perform unsupervised exercises three times a week, using the provided templates | 6 weeks | Post-acute phase | Significant difference of exercise capacity (STST change) between rehabilitation group and control ( Non-significant difference of respiratory function (dyspnea) between rehabilitation group and control ( |
| Olezene et al. 2021 [ | Cross-sectional | 29 | 60 (50.5–67.5) | Severe | At least three hours per day, five days per week, individualized rehabilitation | Mean: 16.7 ± 7.8 days | Post-acute phase | Significant improvement in Exercise capacity (including Berg Balance Scale |
| Rosen et al. 2020 [ | Cross-sectional | 12 | Median: 56 | COVID-19 inpatients | Inpatient telerehabilitation (included patient education, therapeutic exercises, and breathing techniques) | 1–2 sessions | Acute phase | None of the patients required increased oxygen supplementation or medical care after rehabilitation |
| Udina et al. 2021 [ | Cohort | 33 | 66.2 (12.8) | Survived COVID-19 patients. 60.6% of them were ICU admitted | A 30-min daily multicomponent exercise training including resistance, endurance and balance training | Up to 10 days | Post-acute phase | Significant improvement in Exercise capacity (including SPBB, BI, ability to walk unassisted, and single leg stance). |
| Zampogna et al. 2021 [ | Cross-sectional | 140 | 71 (61.5–78) | Recovered patients with negative RT-PCR test for SARS-CoV-2 | Individually tailored training including both group and personal exercise programs with one or more of the following trainings; mobilization, active exercises and free walking, limb muscle activities, shoulder, and full arm circling, callisthenic, strengthening, balance exercise, paced walking, cycle-ergometer at low-intensity exercises (< 3.0 METs), and chest physiotherapy | Median: 24.0 (19.0–34.0) days, 60 (38–84) sessions, 2.8 (1.0–3.8) daily sessions | Post-acute phase | Significant improvement in exercise capacity (including SPPB, |
| Zha et al. 2020 [ | Cohort | 60 | 54 (38–62) | mild, and no CT evidence of pneumonia on admission | The modified rehabilitation exercise (MRE), including Overhead Chest and Shoulder Stretch, Heel Raises and Upper Body Acupressure, Upper Body Rotation, and Hand Acupressure Massage | NA | Acute phase | Improvement in All respiratory symptoms (including dry cough, productive cough, difficulty in expectoration and dyspnea) |
| Zhang et al. 2021 [ | Cross-sectional | 91 | NA | Mild cases or common clinical types | Baduanjin exercise | NA | Acute phase | Correlation between higher frequency of Baduanjin exercise and improvement in Psychological aspects including HAD anxiety ( |
BI, Barthel Index; CPET, CardioPulmonary Exercise Test; DLCO, Diffusing Capacity for Carbon monoxide; FEV1, Forced Expiratory Volume in One second; FVC, Forced Vital Capacity; HADS, Hospital Anxiety and Depression Scale; HPT, home physical therapy; IE, independent exercise program; MEP, Maximal Expiratory Pressure; MIP: Maximal Inspiratory Pressure; MoCA, Montreal Cognitive Assessment; MRC, Medical Research Council; PEFR, Peak Expiratory Flow Rate; PEmax, Maximal Expiratory Pressure; PImax, Maximal Inspiratory Pressure; P/F ratio, PaO2/FIO2; SpO2, Pulse Oximeter Oxygen Saturation; SPPB, Short Physical Performances Battery; STS, Step Test Score; STSS, Sit To Stand Score; STST, Sit To Stand Test; TLC, Total Lung Capacity; VO2, oxygen consumption; VPT, virtual physical therapy; 6MWD, 6-min walking distance